EQT Fund Management S.a r.l. Diversified Active

Location: Luxembourg

CIK: 0001834239 · Show all filings

Period: Q1 2026 (← Previous) (Next →)

Filing Date: May 14, 2026

Total Value: $1.021B (100.0% shares, 0.0% debt)

Holdings (5)

WAY WAYSTAR HLDG CORP 58.8%

Value $600M Shares 24,879,437 Est. Cost $37.06 Unrealized -25.8%

OCS OCULIS HOLDING AG 15.4%

Value $157M Shares 5,900,294 Est. Cost $17.72 Unrealized +49.4%

EVMN EVOMMUNE INC 11.1%

Value $113M Shares 4,929,633 Est. Cost $18.78 Unrealized +17.1%

PHVS PHARVARIS N V 9.5%

Value $96.75M Shares 3,424,609 Est. Cost $22.18 Unrealized +20.6%

AGMB AGOMAB THERAPEUTICS NV 5.3%

Value $53.94M Shares 5,141,992 Est. Cost $10.49 Unrealized —

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
WAY	WAYSTAR HLDG CORP	24,879,437	$600M	58.8%	$37.06	-25.8%	COM	946784105
OCS	OCULIS HOLDING AG	5,900,294	$157M	15.4%	$17.72	+49.4%	ORDINARY SHARES	H5870P102
EVMN	EVOMMUNE INC	4,929,633	$113M	11.1%	$18.78	+17.1%	COM SHS	30054Y107
PHVS	PHARVARIS N V	3,424,609	$96.75M	9.5%	$22.18	+20.6%	COM	N69605108
AGMB	AGOMAB THERAPEUTICS NV	5,141,992	$53.94M	5.3%	$10.49	—	SPONSORED ADS	00860C102